##plugins.themes.bootstrap3.article.main##


Carolina García Alfonso https://orcid.org/0000-0002-1712-0434

Andrea Estefania Martínez Reyes

Valentina García

Andres Ricaurte Fajardo

Isabel Torres

Juliana Coral Casas

Resumen

El ataque cerebrovascular (ACV) agudo es la segunda causa de muerte en el mundo y genera costos elevados en su tratamiento y recuperación, así como un gran impacto socioeconómico, pues es la principal causa de discapacidad a largo plazo. Si bien la tomografía axial computarizada (TAC) cerebral simple sigue siendo la imagen recomendada por las guías internacionales para la evaluación inicial y toma de decisiones sobre el manejo del paciente con sospecha de ACV, en los últimos años ha habido extraordinarios avances en el diagnóstico oportuno y temprano del ACV con nuevas herramientas que van desde la estandarización de la angiotomografía cerebral como uno de los estudios principales en el enfoque inicial hasta el uso de técnicas de perfusión por tomografía y resonancia magnética (RM) cerebral, que permiten establecer el núcleo del infarto y el área circundante potencialmente salvable, por lo que es posible ofrecer terapias que brindan al paciente funcionalidad y calidad de vida a mediano y largo plazo. Teniendo en cuenta lo anterior, es vital actualizar los métodos diagnósticos actuales disponibles en el país y las distintas terapias disponibles, según sea el caso de cada paciente, para el ACV isquémico agudo, con un enfoque clínico práctico y aplicable al escenario actual de salud en Colombia.

##plugins.themes.bootstrap3.article.details##

Keywords

ataque cerebrovascular agudo, ictus, infarto cerebral, terapia trombolítica, trombólisis

References
1. Ministerio de Salud y Protección Social. Guía de práctica clínica para el diagnóstico, tratamiento y rehabilitación del episodio agudo del ataque cerebrovascular isquémico en población mayor de 18 años. Vol. 54, CINET. 2015. 1-52.

2. Arauz A, Ruiz-Franco A. Enfermedad vascular cerebral. Rev Fac Med (Méx.). 2012;55(3):11-21.

3. Mikulik R, Wahlgren N. Treatment of acute stroke: an update. J Intern Med. 2015;278:145-65.

4. Maldonado N, Kazmi S, Suárez J. Update in the management of acute ischemic stroke. Crit Care Clin. 2014;30:673-97.

5. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:146-603.

6. Pradilla AG, Vesga BE, León-Sarmiento FE. Estudio neuroepidemiológico nacional (Epineuro) colombiano. Rev Panam Salud Pública. 2003;14:104-11.

7. Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10:471.

8. Lin MP, Liebeskind DS. Imaging of ischemic stroke. Continuum (NY). 2016;22:1399-423.

9. Jordan JD, Powers WJ. Cerebral Autoregulation and Acute Ischemic Stroke. Am J Hypertens. 2012;25:946-50.

10. Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke. 2010;41:2697-704.

11. Faraci FM. Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol. 2006;100:739-43.

12. Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17:197.

13. Zarco L, González F, Coral J. Tratamiento actual del ataque cerebrovascular isquémico (ACV) agudo. Univ Méd (Bogotá). 2008;49:467-98.

14. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep. 2011;13:200-7.

15. Lu GW, Liu HY. Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. J Appl Physiol. 2001;91:1193-8.

16. Love S. Oxidative stress in brain ischemia. Brain Pathol. 1999;9:119-31.

17. Dugan LL, Choi DW. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol. 1994;35:S17-21.

18. Brott T, Jr HPA, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-70.

19. Angosto MC. Bases moleculares de la apoptosis. Académica Número la Real Acad Nac Farm. 2003;69:36-64.

20. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365-75.

21. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke. 2006;37:1334-9.

22. Staykov D, Gupta R. Hemicraniectomy in malignant middle cerebral artery infarction. Stroke. 2011;42:513-6.

23. Simard JM, Chen M, Tarasov K V., Bhatta S, Ivanova S, Melnitchenko L, et al. Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433-40.

24. Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab. 2016;36:513-38.

25. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.

26. Alexandru R, Terecoasă EO, Tiu C. Etiologic classification of ischemic stroke: Where do we stand? Clin Neurol Neurosurg. 2017;159:93-106.

27. Molina-Seguin J, Vena AB, Colàs-Campàs L, Benalbdelhak I, Purroy F. Revisión sistemática de las características y pronóstico de los sujetos que sufren un ictus criptogénico no lacunar de mecanismo embólico. Neurología. 2018;66:325-30.

28. Pare JR, Kahn JH. Basic neuroanatomy and stroke syndromes. Emerg Med Clin North Am. 2012;30:601-15.

29. Wintermark M, Sanelli PC, Albers GW, Bello JA, Derdeyn CP, Hetts SW, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol. 2013;20:828-32.

30. Southerland AM. Clinical evaluation of the patient with acute stroke. Continuum. 2017;23:40-61.

31. Birenbaum D, Bancroft LW, Felsberg GJ. Imaging in acute stroke. West J Emerg Med. 2011;12:67-76.

32. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018:46-110.

33. Hill M, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003;34:1925-31.

34. Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radiol. 2017;96:162-72.

35. Bouchez L, Sztajzel R, Vargas MI, et al. CT imaging selection in acute stroke. Eur J Radiol. 2017;96:153-61.

36. Martinon E, Lefevre PH, Thouant P, Osseby GV, Ricolfi F, Chavent A. Collateral circulation in acute stroke: assessing methods and impact: a literature review. J Neuroradiol. 2014;41:97-107.

37. Hao Y, Yang D, Wang H, Zi W, Zhang M, Geng Y, et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke. Stroke. 2017;48:1203-9. https://doi.org/10.1161/STROKEAHA.116.016368.

38. Havenon A, Mlynash M, Kim-Tenser MA, et al. DEFUSE 3: Good collaterals are associated with reduced ischemic core growth but not neurologic outcome. Stroke. 2019;50(3):632-8.

39. Brozici M, van der Zwan A, Hillen B. Anatomy and functionality of leptomeningeal anastomoses: a review. Stroke. 2003;34:2750-62.

40. Donnan GA, Davis SM. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol. 2002;1:417-25.

41. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct- DAWN. N Engl J Med. 2018; 378:11-21.

42. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutiérrez S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging-DEFUSE 3. N Engl J Med. 2018;708-18.

43. Srinivasan A, Goyal M, al Azri F, Lum C. State-of-the-art imaging of acute stroke. RadioGraphics. 2006;26:S75-95.

44. Cockroft KM, Prestigiacomo CJ, Duffis EJ, Gandhi CD. Cerebral angiography: surgical endovascular neuroradiology. New York: Thieme; 2015.

45. Jayaraman MV, Grossberg JA, Meisel KM, Shaikhouni A, Silver B. The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-arterial stroke therapy. Am J Neuroradiol. 2013;34:135-9.

46. Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke. 2015;46:3020-35.

47. Pahs L, Droege C, Kneale H, Pancioli A. A novel approach to the treatment of orolingual angioedema after tissue plasminogen activator administration. Ann Emerg Med. 2016;68:345-8.

48. Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6-46.

49. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, et al. MERCI 1: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke. 2004;35:2848-53.

50. Po Sit S, Langer D, Stingele R. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761-8.

51. Costalat V, MacHi P, Lobotesis K, Maldonado I, Vendrell JF, Riquelme C, et al. Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: A prospective 50-patient single-center study: Timing, safety, and efficacy-RECOST. Stroke. 2011;42:1929-35.

52. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-9.

53. Berkhemer O, Fransen PS, Beumer D, Lingsma H. A Randomized trial of intraarterial treatment for acute ischemic stroke - MR CLEAN. N Engl J Med. 2015;372:2747-57.

54. Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection-EXTEND-IA. N Engl J Med. 2015;372:1009-18.

55. Demchuk AM, Goyal M, Menon BK, Eesa M, Ryckborst KJ, Kamal N, et al. Endovascular treatment for small core and anterior circulation proximal occlusion with emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke. 2015;10:429-38.

56. Molina CA, Chamorro A, Rovira À, de Miquel A, Serena J, Roman LS, et al. REVASCAT: A randomized trial of revascularization with SOLITAIRE FR® device vs. best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke. 2015;10:619-26.

57. Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Continuum (Minneap Minn). 2017;23:15-39.

58. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-59.
Cómo citar
García Alfonso, C., Martínez Reyes, A., García, V., Ricaurte Fajardo, A., Torres, I., & Coral Casas, J. (2019). Actualización en diagnóstico y tratamiento del ataque cerebrovascular isquémico agudo. Universitas Medica, 60(3), 1-17. https://doi.org/10.11144/Javeriana.umed60-3.actu
Sección
Artículos de revisión
Artículos más leídos del mismo autor/a